The two ETFs have been lifted Israel’s accommodative monetary policy and health care exposure, among other catalysts. EIS and ISRA each feature health care as their second-largest second allocation at weights of 24.5% and 30.4%, respectively. Teva Pharmaceuticals (NasdaqGS: TEVA) is the largest holding in both ETFs at weights of 23.8% in EIS and 14.4% in ISRA. [Teva Could Lift These ETFs]
ISRA in particular has benefited from its 31% weight to technology stocks, a positive as Israel is home to one of the world’s most thriving start-up markets, a catalyst that could lead to increased tech initial public offerings.
“Currently, momentum investors should consider looking at single-country ETFs that invest in the U.S., South Africa, Israel, Canada, and Spain. With the exception of South Africa and Israel, the rest of the countries on this list are relatively expensive,” said Accuvest.
Market Vectors Israel ETF